Navigation Links
AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform
Date:10/8/2009

WASHINGTON, Oct. 8 /PRNewswire/ -- As Congress wraps up work on health care reform, members of the American Society of Transplantation's (AST) Public Policy Committee arrived on Capitol Hill today to discuss the importance of supporting a health care provision that would ensure kidney transplant recipients continue to receive Medicare coverage for immunosuppressive drugs. The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009, in the health care reform bill, is currently on the floor of the U.S. Senate and has been included in the House health care reform bill. Extending immunosuppressive coverage under Medicare will improve the long term health of kidney recipients and is cost-effective to taxpayers.

While on Capitol Hill, AST Public Policy members will meet with congressional representatives of the Senate Appropriations Committee, House Energy and Commerce Committee, House Ways and Means Committee, House Science Committee, and House Education and Labor Subcommittee on Families and Community.

Medicare and Immunosuppressive Drug Coverage

The Medicare Program pays for kidney transplantation, an initial investment of more than $100,000. By providing Medicare coverage for a patient's immunosuppressant drugs, the Medicare transplant investment is protected and preserved. Most individuals with end stage renal disease (ESRD) are eligible for Medicare regardless of age or other disability. Under current law kidney transplant recipients, if not aged or disabled, lose their Medicare immunosuppressive drug coverage 36 months post-transplant. Without such drugs, a transplanted kidney may fail and Medicare is then faced with re-transplantation or a return to costly dialysis. By contrast, there is no Medicare time or cost limit for dialysis patients. Medicare spends approximately $70,000 per dialysis beneficiary every year.

About the AST Public Policy Committee

AST represents the majority of professionals engaged in the field of solid organ transplantation. The AST Public Policy Committee regularly delivers AST's message to Congress and the Administration. This strategy has been effective in ensuring that members of Congress and Capitol Hill staff are aware of the issues that impact transplantation.

About AST

The American Society of Transplantation is an international organization of transplant professionals dedicated to advancing the field of transplantation through the promotion of research, education, advocacy, and organ donation to improve patient care. The Society comprises over 3,100 transplant physicians, surgeons and allied health professionals.

For information about AST, visit www.a-s-t.org.

    CONTACT: BETH DROST
    (215) 884-6499
    beth@comsolutionsgroup.com

SOURCE American Society of Transplantation


'/>"/>
SOURCE American Society of Transplantation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report
4. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
5. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
6. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
7. WORLDS First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
8. IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant
9. Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients
10. Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
11. Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for the ... Europe , Asia-Pacific , Latin ... provided for the period 2015 through 2022. Also, a six-year historic analysis ...
(Date:3/24/2017)... -- HealthMine surveys with 9,250 insured consumers fielded from February ... want help from their plans in five key areas: ... 2) help closing gaps in care, 3) better digital ... relevant, real-time guidance. Meeting these needs is essential to ... A Reason to Stay Engaged in Health ...
(Date:3/24/2017)... and GENEVA , March 24, ... World Tuberculosis Day revitalizes efforts to develop sutezolid as ... On World Tuberculosis Day, TB Alliance and the Medicines ... clinical development of sutezolid, an antibiotic drug candidate which ... to the development of sutezolid in combination with other ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... ... (ONS) wanted to create a communications platform that positions them as the go-to ... and ONS reinvented their online publication as an always-on, always-fresh news, views and ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ( ... patients for colonoscopy at the HyGIeaCare® Center that is to be located adjacent ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration ...
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The physicians of ... in the greater Houston Area. The new location is located at 2255 E. Mossy ... in Springwoods Village. This newest location will provide patients living in the north Houston ...
(Date:3/23/2017)... ... ... The MBI “Hall of Fame” recognizes the contributions of those whose careers are or were ... careers of all others involved. , On Monday, March 21st, 2017 Laurie Robert, ... Fame. The induction took place during the World of Modular – Award Gala in ...
Breaking Medicine News(10 mins):